ETF comparison

VHTvsXBI

Both Healthcare.

Vanguard Health Care Index Fund ETF Shares · State Street SPDR S&P Biotech ETF

Holdings overlap

Weighted by ISIN/CUSIP
12.9%

125 positions appear in both funds. Buying equal dollars of VHT and XBI would leave roughly12.9%of each dollar exposed to the same underlying securities.

VHT only 86.9%Shared 12.9%XBI only 87.0%
In VHT only
273 positions
Shared
125 positions
In XBI only
32 positions

Side by side

VHT

Vanguard Health Care Index Fund ETF Shares

Vanguard · Healthcare

84composite / 100
Expense ratio
0.090%
Net assets
$22.04B
TTM yield
1.52%
Top-10 conc.
51.9%
XBI

State Street SPDR S&P Biotech ETF

State Street · Healthcare

81composite / 100
Expense ratio
0.35%
Net assets
$11.40B
TTM yield
0.36%
Top-10 conc.
18.0%

Sub-score comparison

91
Cost
65
82
Tax efficiency
85
100
Liquidity
100
40
Concentration
89
Tracking quality
VHTsub-scoreXBI

Tracking quality isn't part of the composite — seewhat we don't scorefor why.

Cost difference

VHT is 26 bps cheaper than XBI. On a $100,000 position that's about $260/yr more in fees for XBI.

Fee figure is the annual expense charged on $100,000. To see how the gap compounds over a multi-decade holding period, open thecost calculator pre-filled with VHT vs XBI.

Top shared holdings

125 shared in total
#HoldingIn VHTIn XBIOverlap
1Vertex Pharmaceuticals Inc1.80%1.06%1.06%
2AbbVie Inc6.09%1.04%1.04%
3Amgen Inc2.87%0.99%0.99%
4Gilead Sciences Inc2.64%0.96%0.96%
5Regeneron Pharmaceuticals Inc1.00%0.96%0.96%
6Alnylam Pharmaceuticals Inc0.63%0.96%0.63%
7Natera Inc0.46%1.16%0.46%
8Biogen Inc0.45%1.03%0.45%
9REVOLUTION Medicines Inc0.40%1.20%0.40%
10Insmed Inc0.36%1.08%0.36%
11United Therapeutics Corp0.36%0.92%0.36%
12Incyte Corp0.26%1.00%0.26%

Only in VHT

273 total
  • Eli Lilly & Co14.04%
  • Johnson & Johnson8.47%
  • UnitedHealth Group Inc5.45%
  • Merck & Co Inc4.66%
  • Thermo Fisher Scientific Inc2.93%
  • Intuitive Surgical Inc2.38%
  • Pfizer Inc2.35%
  • Abbott Laboratories2.35%
  • Bristol-Myers Squibb Co1.84%
  • Danaher Corp1.84%

Only in XBI

32 total
  • SELLAS Life Sciences Group Inc1.19%
  • uniQure NV1.03%
  • CRISPR Therapeutics AG1.02%
  • Absci Corp0.56%
  • Capricor Therapeutics Inc0.49%
  • Hyperliquid Strategies Inc0.46%
  • Inhibrx Biosciences Inc0.35%
  • Avalo Therapeutics Inc0.35%
  • Jade Biosciences Inc0.32%
  • Vor BioPharma Inc0.30%

Open VHT or XBI at a brokerage

Both funds trade commission-free at major US brokerages.

Affiliate links — opening an account through these earns PlainIndex a one-time referral. Scoring is computed before any affiliate consideration; see our methodologyand funding disclosure.

Holdings overlap is the sum of min(weight_a, weight_b) over positions matched on ISIN (CUSIP fallback). Methodology: see/methodology/.

Comparing two funds doesn't endorse swapping one for the other. Tax-lot history, account type, and personal goals matter — PlainIndex publishes data and methodology, not investment advice.